The American Journal of Medicine
Volume 121, Issue 7 , Pages 562-564, July 2008

Perspectives on “Chronic Lyme Disease”

  • Phillip J. Baker, PhD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Phillip J. Baker, PhD, Post Office Box 466, Lyme, CT 06371.

American Lyme Disease Foundation, Lyme, Connecticut.

Abstract 

There is much controversy about the treatment of Lyme disease with respect to 2 poorly defined entities: “chronic Lyme disease” and “posttreatment Lyme disease syndrome.” In the absence of direct evidence that these conditions are the result of a persistent infection, some mistakenly advocate extended antibiotic therapy (≥6 months), which can do great harm and has resulted in at least 1 death. The purpose of this brief report is to review what is known from clinical research about these conditions to assist both practicing physicians and lawmakers in making sound and safe decisions with respect to treatment.

Keywords: Adverse effects of extended antibiotic therapy, Antibiotic therapy, Borrelia burgdorferi, Chronic Lyme disease, Extended antibiotic treatment, Lyme disease, Neuroprotective effects of antibiotics, Posttreatment Lyme disease syndrome

 

PII: S0002-9343(08)00181-2

doi:10.1016/j.amjmed.2008.02.013

The American Journal of Medicine
Volume 121, Issue 7 , Pages 562-564, July 2008